A phase I, open label, controlled, intra-subject comparison study to investigate the effect of co-administration upon the pharmacokinetics of tipranavir (ritonavir boosted) and apricitabine.
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Apricitabine (Primary) ; Ritonavir; Tipranavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Avexa
- 10 Jan 2007 Added information from 9071343.
- 10 Oct 2006 New trial record.